6 completed. 6 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 6 | Completed 6 |
| Phase 2 | 1 | Completed 1 |
Follow Ovarian Sarcoma: new trials by email Literature Review of Ovarian Sarcoma trials Research Report on Ovarian Sarcoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Carboplatin, Gemcitabine Hydrochloride, and Stereotactic Body Radiation Therapy in Gynecological Cancer stereotactic body radiation therapy, carboplatin, gemcitabine hydrochloride - Leydig Cell Tumor, Ovarian Sarcoma | Phase 1 | Completed | Case Comprehensive Cancer Center | 12 | 2012-05-01 | 2015-08-04 |
| Vismodegib and Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced or Metastatic Sarcoma Gamma-Secretase Inhibitor RO4929097, Laboratory Biomarker Analysis, Pharmacological Study - Adult Alveolar Soft Part Sarcoma, Adult Angiosarcoma | Phase 1 / Phase 2 | Completed | National Cancer Institute (NCI) | 78 | 2010-06-01 | 2018-08-15 |
| Temsirolimus, Carboplatin, and Paclitaxel in Treating Patients With Advanced Solid Tumors paclitaxel, carboplatin, temsirolimus - Ovarian Sarcoma, Ovarian Stromal Cancer | Phase 1 | Completed | National Cancer Institute (NCI) | 38 | 2007-02-01 | 2014-06-19 |
| 7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007) 7-hydroxystaurosporine, irinotecan hydrochloride, diagnostic laboratory biomarker analysis - Advanced Adult Primary Liver Cancer, Carcinoma of the Appendix | Phase 1 | Completed | National Cancer Institute (NCI) | 41 | 2001-12-01 | 2013-09-30 |
| Vaccine Therapy in Treating Patients With Metastatic Cancer interleukin-2, MAGE-12 peptide vaccine, Montanide ISA-51 - Lung Cancer, Adult Soft Tissue Sarcoma | Phase 1 | Completed | National Cancer Institute (NCI) | 2000-07-01 | 2024-03-04 | |
| 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Advanced Epithelial Cancer, Malignant Lymphoma, or Sarcoma tanespimycin, pharmacological study - AIDS-related Peripheral/Systemic Lymphoma, AIDS-related Primary CNS Lymphoma | Phase 1 | Completed | National Cancer Institute (NCI) | 60 | 1999-10-01 | 2013-02-07 |
Carcinoma, Ovarian Epithelial (3) · Endometrial Neoplasms (3) · Neuroectodermal Tumors, Primitive, Peripheral (3) · Osteosarcoma (3) · Sarcoma (3) · Breast Neoplasms (2) · Carcinoma, Non-Small-Cell Lung (2) · Chondrosarcoma (2) · Colonic Neoplasms (2) · Gastrointestinal Stromal Tumors (2) · Histiocytoma, Malignant Fibrous (2) · Rectal Neoplasms (2) · Uterine Cervical Neoplasms (2) · Anus Neoplasms (1) · Appendiceal Neoplasms (1)
Neoplasms by Histologic Type (6) · Neoplasms, Glandular and Epithelial (6) · Neoplasms (5) · Neoplasms by Site (5) · Neoplasms, Connective Tissue (4) · Neoplasms, Connective and Soft Tissue (4) · Neoplasms, Germ Cell and Embryonal (4) · Neoplasms, Nerve Tissue (4) · Neoplasms, Neuroepithelial (4) · Neuroectodermal Tumors (4) · Neuroectodermal Tumors, Primitive (4) · Adnexal Diseases (3) · Carcinoma (3) · Digestive System Diseases (3) · Digestive System Neoplasms (3)
Carboplatin (2) · 2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide (1) · 7-hydroxystaurosporine (1) · Gemcitabine (1) · HhAntag691 (1) · Interleukin-2 (1) · Irinotecan (1) · Paclitaxel (1) · Pharmacogenomic Testing (1) · Radiosurgery (1) · Sirolimus (1) · Taxes (1) · montanide ISA 51 (1) · tanespimycin (1) · temsirolimus (1)
National Cancer Institute (NCI) (5) · Case Comprehensive Cancer Center (1)
United States (5) · Canada (1)
Amit Oza (1) · Francesco M. Marincola (1) · Mrinal Gounder (1) · Paula Fracasso (1) · Ramesh Ramanathan (1) · Steven Waggoner, MD (1)
N01CM62206 (1), P30CA008748 (1), P30CA044579 (1), U01CA069856 (1), U01CA099168 (1)